Cargando…
Inhibition of Radiation and Temozolomide-Induced Glioblastoma Invadopodia Activity Using Ion Channel Drugs
SIMPLE SUMMARY: Glioblastoma accounts for approximately 40–50% of all primary brain cancers and is a highly aggressive cancer that rapidly disseminates within the surrounding normal brain. Dynamic actin-rich protrusions known as invadopodia facilitate this invasive process. Ion channels have also be...
Autores principales: | Dinevska, Marija, Gazibegovic, Natalia, Morokoff, Andrew P., Kaye, Andrew H., Drummond, Katharine J., Mantamadiotis, Theo, Stylli, Stanley S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599723/ https://www.ncbi.nlm.nih.gov/pubmed/33050088 http://dx.doi.org/10.3390/cancers12102888 |
Ejemplares similares
-
Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells
por: Jones, Dylan, et al.
Publicado: (2022) -
Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved Drugs
por: Whitehead, Clarissa A., et al.
Publicado: (2018) -
Small extracellular vesicles promote invadopodia activity in glioblastoma cells in a therapy-dependent manner
por: Whitehead, Clarissa A., et al.
Publicado: (2023) -
The role of interleukin-6-STAT3 signalling in glioblastoma
por: West, Alice J., et al.
Publicado: (2018) -
Therapeutic Targeting of Cancer Stem Cells in Human Glioblastoma by Manipulating the Renin-Angiotensin System
por: Tan, David C. H., et al.
Publicado: (2019)